Researchers at Stanford University have identified a compound in edible sea squirts that appears to reverse several signs of aging in older mice, offering a potential new avenue for addressing age-related cognitive decline. The substance, known as plasmalogen, was found to improve memory and learning, strengthen connections between brain cells, reduce inflammation, and even restore thicker, darker hair in the animals. The findings, published in a recent study, suggest that plasmalogen supplements may encourage brain regeneration and protect aging synapses, the junctions where neurons communicate.
Plasmalogens are a class of lipids that are abundant in cell membranes, particularly in the brain, heart, and immune cells. Their levels naturally decline with age, and lower levels have been linked to neurodegenerative conditions such as Alzheimer's disease. The Stanford team, led by researchers in the Department of Neurology and Neurological Sciences, tested the effects of plasmalogen supplementation on older mice, which typically show age-related declines in memory and synaptic function. After a period of treatment, the mice demonstrated significant improvements in cognitive tests, including maze navigation and object recognition, compared to untreated controls.
The study also examined the underlying mechanisms. The researchers observed increased expression of genes involved in synaptic plasticity, the process by which synapses strengthen or weaken over time, which is critical for learning and memory. Additionally, plasmalogen treatment reduced markers of neuroinflammation, a key contributor to age-related brain deterioration. The hair regrowth observed in the mice was an unexpected but notable outcome, suggesting that the compound may have systemic effects beyond the brain, possibly by reducing oxidative stress or improving cellular health.
Sea squirts, also known as tunicates, are marine invertebrates that are consumed in some cultures, particularly in Asia, where they are considered a delicacy. They are one of the richest natural sources of plasmalogens, which has drawn interest from researchers studying aging. The Stanford team chose to study plasmalogens because of their known role in maintaining cell membrane integrity and their decline with age. Previous research has linked low plasmalogen levels to conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, making them a promising target for therapeutic intervention.
The findings add to a growing body of evidence that dietary compounds can influence the aging process. However, the researchers caution that the results are preliminary and have not yet been tested in humans. Plasmalogen supplements are already available on the market, but their efficacy and safety in people remain unproven. The Stanford team plans to conduct further studies to determine whether the benefits observed in mice translate to humans, and to explore the optimal dosage and delivery methods.
If confirmed in human trials, plasmalogen supplementation could offer a non-invasive approach to supporting brain health in older adults, potentially slowing the progression of age-related cognitive decline. The study also highlights the value of exploring marine organisms as a source of bioactive compounds with therapeutic potential. As the global population ages, interventions that can preserve cognitive function and quality of life are of increasing importance, and this research represents a step toward that goal.
